Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals

Journal of Clinical Oncology

Volumn 20, Issue 6, 2002, Pages 1480-1490

  Frank, Thomas S ^a   Deffenbaugh, Amie M ^a   Reid, Julia E ^a   Hulick, Mark ^a   Ward, Brian E ^a   Lingenfelter, Beth ^a   Gumpper, Kathi L ^a   Scholl, Thomas ^a   Tavtigian, Sean V ^a   Pruss, Dmitry R ^a   Critchfield, Gregory C ^a  

^a Myriad Genetic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CHILD; CLINICAL FEATURE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; SEX;

ADULT; BRCA2 PROTEIN; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; FEMALE; FOUNDER EFFECT; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; JEWS; MALE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 0037087536     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.6.1480     Document Type: Article

References (31)

1. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
2. Human cancer syndromes: Clues to the origin and nature of cancer
3. Ashkenazi Jewish population frequencies for common mutations in BRCA 1 and BRCA2
4. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families
5. A suggested nomenclature for designating mutations
6. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: A genetic study of 15 185delAG-mutation kindreds
7. The accuracy of patient reports of a family history of cancer
8. The genetics of breast cancer susceptibility
9. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
10. The genetic attributable risk of breast and ovarian cancer
11. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
12. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
13. High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history
14. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
15. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
16. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women
17. BRCA1 mutations in African Americans
18. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer
19. Borderline epithelial lesions of the breast
20. In-situ breast cancer and BRCA1
21. BRCA1 mutations and breast cancer in the general population: Analyses in women before age 35 years and in women before age 45 years with first-degree family history
22. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13
23. BRCA2 germline mutations in male breast cancer cases and breast cancer families
24. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population
25. Blinded comparison of methods for detecting germline BRCA1 mutations: Implications for molecular epidemiologic research and the practice of molecular medicine
26. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing
27. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
28. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations
29. An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10
30. Color bar coding the BRCA1 gene on combed DNA: A useful strategy for detecting large gene rearrangements